Published ahead of print on November 25, 2003, doi:10.1164/rccm.200306-774OC
American Journal of Respiratory and Critical Care Medicine Vol 169. pp. 505-511, (2004)
© 2004 American Thoracic Society
Overexpression of Placenta Growth Factor Contributes to the Pathogenesis of Pulmonary Emphysema
Po-Nien Tsao,
Yi-Ning Su,
Hung Li,
Pei-Hsin Huang,
Chiang-Ting Chien,
Yih-Loong Lai,
Chien-Nan Lee,
Chi-An Chen,
Wen-Fang Cheng,
Shu-Chen Wei,
Chong-Jen Yu,
Fon-Jou Hsieh and
Su-Ming Hsu
Departments of Medical Genetics, Pediatrics, Pathology, Medical Research Administration, Obstetrics and Gynecology, and Internal Medicine, National Taiwan University Hospital; Department of Physiology, College of Medicine, National Taiwan University; and Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan, Republic of China
Correspondence and requests for reprints should be addressed to Fon-Jou Hsieh, M.D., Department of Obstetrics and Gynecology, College of Medicine, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei, Taiwan. E-mail: fjhsieh{at}ha.mc.ntu.edu.tw
To examine the role of placenta growth factor (PlGF) in the pathogenesis of pulmonary emphysema, we generated PlGF-transgenic (TG) mice using a phosphoglycerate kinase promoter. This resulted in constitutive overexpression of PlGF. In these TG mice, pulmonary emphysema, with enlarged air spaces and enhanced pulmonary compliance, first appeared at 6 months of age and became prominent at 12 months. Increased alveolar septal cell apoptosis was noted in their lungs. Fluorescence-activated cell sorter analysis suggests that these apoptotic septal cells are type II pneumocytes. At the same time, the messenger RNA of vascular endothelial growth factor and platelet-endothelial cell adhesion molecule-1, an endothelial cell marker, were downregulated indicating a reduced number of endothelial cells and its survival factor VEGF. In vitro, exogenous PlGF can inhibit the proliferation and promote the cell death of mouse type II pneumocytes. In normal newborn mice, abundant expression of PlGF messenger RNA was detected in the lungs during saccular division but was rapidly downregulated after alveolarization was complete. Thus, a persistently elevated PlGF was detrimental to the developed lung and causes the emphysematous change seen in our TG mice. Our study suggests that PlGF plays an important role in the pathogenesis of pulmonary emphysema via its action on type II pneumocytes.
Key Words: placenta growth factor pulmonary emphysema transgenic mice
This article has been cited by other articles:

|
 |

|
 |
 
S-L Cheng, H-C Wang, C-J Yu, and P-C Yang
Increased expression of placenta growth factor in COPD
Thorax,
June 1, 2008;
63(6):
500 - 506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sharafkhaneh, N. A. Hanania, and V. Kim
Pathogenesis of Emphysema: From the Bench to the Bedside
Proceedings of the ATS,
May 1, 2008;
5(4):
475 - 477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yoshida and R. M. Tuder
Pathobiology of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease
Physiol Rev,
July 1, 2007;
87(3):
1047 - 1082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Mohammed, N. Nasreen, R. S. Tepper, and V. B. Antony
Cyclic stretch induces PlGF expression in bronchial airway epithelial cells via nitric oxide release
Am J Physiol Lung Cell Mol Physiol,
February 1, 2007;
292(2):
L559 - L566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-W. Chen, S.-F. Su, C.-T. Chien, W.-H. Lin, S.-L. Yu, C.-C. Chou, J. J. W. Chen, and P.-C. Yang
Titanium dioxide nanoparticles induce emphysema-like lung injury in mice
FASEB J,
November 1, 2006;
20(13):
2393 - 2395.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. F. Voelkel, R. W. Vandivier, and R. M. Tuder
Vascular endothelial growth factor in the lung
Am J Physiol Lung Cell Mol Physiol,
February 1, 2006;
290(2):
L209 - L221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kanazawa and J. Yoshikawa
Elevated Oxidative Stress and Reciprocal Reduction of Vascular Endothelial Growth Factor Levels With Severity of COPD
Chest,
November 1, 2005;
128(5):
3191 - 3197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Fabbri, S. P. Peters, I. Pavord, S. E. Wenzel, S. C. Lazarus, W. MacNee, F. Lemaire, and E. Abraham
Allergic Rhinitis, Asthma, Airway Biology, and Chronic Obstructive Pulmonary Disease in AJRCCM in 2004
Am. J. Respir. Crit. Care Med.,
April 1, 2005;
171(7):
686 - 698.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mura, C. C. dos Santos, D. Stewart, and M. Liu
Vascular endothelial growth factor and related molecules in acute lung injury
J Appl Physiol,
November 1, 2004;
97(5):
1605 - 1617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Li, R. Shu, G. Filippatos, and B. D. Uhal
Apoptosis in lung injury and remodeling
J Appl Physiol,
October 1, 2004;
97(4):
1535 - 1542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-N. Tsao, S.-C. Wei, Y.-N. Su, C.-N. Lee, H.-C. Chou, W.-S. Hsieh, and F.-J. Hsieh
Placenta Growth Factor Elevation in the Cord Blood of Premature Neonates Predicts Poor Pulmonary Outcome
Pediatrics,
May 1, 2004;
113(5):
1348 - 1351.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 American Thoracic Society
|
|
|